Form 8-K - Current report:
SEC Accession No. 0001193125-24-055934
Filing Date
2024-03-01
Accepted
2024-03-01 16:06:57
Documents
15
Period of Report
2024-02-27
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d798413d8k.htm   iXBRL 8-K 36268
2 EX-16.1 d798413dex161.htm EX-16.1 1901
  Complete submission text file 0001193125-24-055934.txt   159377

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20240227.xsd EX-101.SCH 2840
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20240227_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20240227_pre.xml EX-101.PRE 10805
16 EXTRACTED XBRL INSTANCE DOCUMENT d798413d8k_htm.xml XML 3489
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

EIN.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 24709647
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)